Kazia Therapeutics annual current ratio
2017
2018
2019
2020
2021
2022
2023
2024
2025
Kazia Therapeutics Current Ratio Growth & History (KZIA)
Kazia Therapeutics's current ratio was 0.35 for fiscal 2025.
View full Kazia Therapeutics company overviewKazia Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | 0.35 | 0.11 | +47.37% |
| 2024 | 2024-06-30 | 0.24 | −1.19 | −83.27% |
| 2023 | 2023-06-30 | 1.42 | 0.02 | +1.39% |
| 2022 | 2022-06-30 | 1.40 | −2.13 | −60.21% |
| 2021 | 2021-06-30 | 3.53 | 1.43 | +67.88% |
| 2020 | 2020-06-30 | 2.10 | −1.85 | −46.84% |
| 2019 | 2019-06-30 | 3.96 | 1.57 | +66.03% |
| 2018 | 2018-06-30 | 2.38 | −1.24 | −34.16% |
| 2017 | 2017-06-30 | 3.62 | — | — |
Kazia Therapeutics quarterly current ratio
Q4.17
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | 2.87 | 2.67 | +1291.80% |
| Q4 2025 | 2025-06-30 | 0.35 | 0.11 | +47.37% |
| Q2 2025 | 2024-12-31 | 0.21 | −0.50 | −70.80% |
| Q4 2024 | 2024-06-30 | 0.24 | −1.19 | −83.27% |
| Q2 2024 | 2023-12-31 | 0.71 | −0.35 | −33.34% |
| Q4 2023 | 2023-06-30 | 1.42 | 0.02 | +1.39% |
| Q2 2023 | 2022-12-31 | 1.06 | — | — |
| Q4 2022 | 2022-06-30 | 1.40 | −2.13 | −60.21% |
| Q4 2021 | 2021-06-30 | 3.53 | 1.43 | +67.88% |
| Q4 2020 | 2020-06-30 | 2.10 | −1.85 | −46.84% |
| Q4 2019 | 2019-06-30 | 3.96 | 1.57 | +66.03% |
| Q4 2018 | 2018-06-30 | 2.38 | −1.24 | −34.16% |
| Q4 2017 | 2017-06-30 | 3.62 | — | — |
Kazia Therapeutics current ratio trends
Over the last five fiscal years, Kazia Therapeutics's current ratio decreased from 2.10 to 0.35, a change of −1.75. The latest reported quarter, Q2 2026, shows 2.87.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kazia Therapeutics source filings ↗